{
  "id": 681240,
  "title": "Allogeneic CAR T Company Prepares to Widen Access to Patients",
  "url": "https://urgent.news/2026/08/12/allogeneic-car-t-company-prepares-to-widen-access-to-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T16:00:39.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/bioprocessing/allogeneic-car-t-company-prepares-to-widen-access-to-patients/"
  },
  "original_language": "en",
  "account": null,
  "summary": "An allogeneic CAR T-cell therapy company is planning a pivotal Phase III randomized-control trial, hoping their products can reach more patients and help those who can’t access autologous therapies. The post Allogeneic CAR T Company Prepares to Widen Access to Patients appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}